Stockscreener 앱 받기
12.75
13.26%
-1.9499
시장 영업 전:
14.22
1.4699
+11.53%
전일 마감가:
$14.70
열려 있는:
$15.06
하루 거래량:
22,375
Relative Volume:
6.13
시가총액:
$43.81M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-56.28%
1개월 성능:
-69.80%
6개월 성능:
-75.18%
1년 성능:
-68.68%
1일 변동 폭
$12.00
$15.75
1주일 범위
$8.20
$17.50
52주 변동 폭
$8.20
$17.50
Eloxx Pharmaceuticals Inc Stock (ELOX) Company Profile
명칭
Eloxx Pharmaceuticals Inc
전화
781-577-5300
주소
P.O. BOX 274, ARLINGTON
Compare ELOX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELOX
Eloxx Pharmaceuticals Inc
|
12.75 | 50.51M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Eloxx Pharmaceuticals Inc Stock (ELOX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-17 | 개시 | Oppenheimer | Outperform |
| 2021-06-30 | 개시 | Mizuho | Buy |
| 2021-05-27 | 개시 | B. Riley Securities | Buy |
| 2020-06-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-09-06 | 개시 | Janney | Buy |
| 2018-12-24 | 개시 | H.C. Wainwright | Neutral |
| 2018-07-03 | 개시 | Citigroup | Buy |
모두보기
Eloxx Pharmaceuticals Inc 주식(ELOX)의 최신 뉴스
Invus-led group holds 9.99% of Eloxx (ELOX) via shares and warrants - Stock Titan
ELOX Technical Analysis & ETF Price Forecast - Intellectia AI
symbol__ Stock Quote Price and Forecast - CNN
ELOX Price Today: Eloxx Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Eloxx Pharma (ELOX) Stock Analysis Report | Financials & Insights - Benzinga
Eloxx (NASDAQ: ELOX) CEO receives 328,833 performance-based stock options - Stock Titan
Eloxx Pharmaceuticals (ELOX) director receives 13,587 stock options grant - Stock Titan
Eloxx (ELOX) director Steven Rubin receives 4,018 stock options at $11 strike - Stock Titan
Eloxx (ELOX) director Stephen Webster receives stock options for 13,587 shares - Stock Titan
ELOX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
ELOX Technical Analysis & Stock Price Forecast - Intellectia AI
ELOX PE Ratio & Valuation, Is ELOX Overvalued - Intellectia AI
ELOX News & Events - Intellectia AI
ELOX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Eloxx Pharmaceuticals, Inc.(NasdaqCM: ELOX) added to NASDAQ Composite Index - marketscreener.com
Form 424B4 Eloxx Pharmaceuticals, - StreetInsider
Eloxx Pharmaceuticals (ELOX) raises ~$66M via stock and pre‑funded warrants - Stock Titan
Eloxx Pharmaceuticals Offering Expected to Close June 10 >ELOX - Moomoo
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering - Pharmaceutical Executive
[EFFECT] Eloxx Pharmaceuticals, Inc. SEC Filing - Stock Titan
Eloxx Pharmaceuticals prices $66.0 million offering, uplists to Nasdaq - scanx.trade
Eloxx Pharmaceuticals: Shares Expected to Start Trading on Nasdaq Capital Market on June 9 >ELOX - Moomoo
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - PR Newswire
Eloxx Pharmaceuticals Inc (ELOXD) Stock PDF (Updated: 2026/06/06) - GuruFocus
ELOX SEC FilingsEloxx Pharmaceut 10-K, 10-Q, 8-K Forms - Stock Titan
Domicilium files Schedule 13G/A reporting 4.9% stake in Eloxx (NASDAQ: ELOX) - Stock Titan
Domicilium Real Estate Fund III LP (ELOX) swaps 1.25M shares for pre-funded warrants - Stock Titan
Total debt per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Working capital per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Book value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Return on invested capital % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Free cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Debt to equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Net current asset value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Asset turnover of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Operating cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Long term debt to total assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
CapEx per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Long term debt to total equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Debt to assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Return on assets % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Price to cash flow ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBIT per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Enterprise value of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Eloxx Pharmaceuticals, Inc. Statistics – OTC:ELOXD - TradingView
Enterprise value to EBITDA ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Total liabilities of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Net margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Total debt of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Eloxx Pharmaceuticals Inc (ELOX) 재무 분석
Eloxx Pharmaceuticals Inc (ELOX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.27%
1.43%
자본화:
|
볼륨(24시간):